1400 related articles for article (PubMed ID: 31400403)
41. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
42. The Gut Microbiota in Inflammatory Bowel Disease.
Sheehan D; Shanahan F
Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
[TBL] [Abstract][Full Text] [Related]
43. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
44. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
45. Role of Lactic Acid Probiotic Bacteria in IBD.
Vemuri R; Gundamaraju R; Eri R
Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
[TBL] [Abstract][Full Text] [Related]
46. [Gut microbiota: Description, role and pathophysiologic implications].
Landman C; Quévrain E
Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
[TBL] [Abstract][Full Text] [Related]
47. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease.
Bekkers M; Stojkovic B; Kaiko GE
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681902
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
Eindor-Abarbanel A; Healey GR; Jacobson K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
[TBL] [Abstract][Full Text] [Related]
49. Gut microbiota and IBD: causation or correlation?
Ni J; Wu GD; Albenberg L; Tomov VT
Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
[TBL] [Abstract][Full Text] [Related]
50. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
51. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
Leonardi I; Li X; Iliev ID
Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
[TBL] [Abstract][Full Text] [Related]
52. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
53. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
54. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
[TBL] [Abstract][Full Text] [Related]
55. [Microbiota and inflammatory bowel disease: an update.].
De Sire R; Talocco C; Petito V; Lopetuso LR; Graziani C; Gasbarrini A; Scaldaferri F
Recenti Prog Med; 2018 Dec; 109(12):570-573. PubMed ID: 30667386
[TBL] [Abstract][Full Text] [Related]
56. The gut microbiota and inflammatory bowel diseases.
Miyoshi J; Chang EB
Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
[TBL] [Abstract][Full Text] [Related]
57. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
58. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings.
Mukherjee S; Joardar N; Sengupta S; Sinha Babu SP
J Nutr Biochem; 2018 Nov; 61():111-128. PubMed ID: 30196243
[TBL] [Abstract][Full Text] [Related]
59. Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease.
Kan L; Zheng Z; Fu W; Ma Y; Wang W; Qian H; Xu L
J Control Release; 2024 Jun; 370():43-65. PubMed ID: 38608876
[TBL] [Abstract][Full Text] [Related]
60. Psoriasis and Gut Microbiome-Current State of Art.
Polak K; Bergler-Czop B; Szczepanek M; Wojciechowska K; Frątczak A; Kiss N
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
